T Cell Therapy Targeting LMP1 and 2 in EBV+VE Lymphomas

$244,182P50FY2007CANIH

Baylor College Of Medicine, Houston TX

Investigators

Stephen Gottschalkcontact

Linked publications & trials

Paper 38986621 Paper 38822527 Paper 38819365 Paper 38746443 Paper 38640255 Paper 38588880 Paper 38506769 Paper 38458188 Paper 38241630 Paper 38149948 Paper 38146016 Paper 38145560 Paper 37958791 Paper 37724110 Paper 37696818 Paper 37691128 Paper 37676964 Paper 37357070 Paper 37072346 Paper 36693154 Paper 36653070 Paper 36592718 Paper 36574622 Paper 36518078 Paper 36517124 Paper 36484736 Paper 36347021 Paper 36122411 Paper 36086817 Paper 36044667 Paper 35821636 Paper 35816634 Paper 35466006 Paper 35325065 Paper 35176142 Paper 35034472 Paper 34800921 Paper 34670275 Paper 34620874 Paper 34568831 Paper 34461635 Paper 34329649 Paper 34323938 Paper 34278937 Paper 33854880 Paper 33762728 Paper 33750078 Paper 33738181 Paper 33536140 Paper 33507803 Paper 33434061 Paper 33276546 Paper 33275669 Paper 33147337 Paper 33130314 Paper 33075814 Paper 32701411 Paper 32661440 Paper 32511892 Paper 32449767 Paper 32437562 Paper 32203679 Paper 32193476 Paper 32155969 Paper 32114498 Paper 32048071 Paper 32034290 Paper 31985805 Paper 31971667 Paper 31932841 Paper 31899802 Paper 31779709 Paper 31558475 Paper 31521464 Paper 31170414 Paper 31135527 Paper 31076527 Paper 31005599 Paper 30985295 Paper 30941128 Paper 30936089 Paper 30891427 Paper 30850208 Paper 30619856 Paper 30613276 Paper 30396848 Paper 30391141 Paper 30309819 Paper 30262660 Paper 30111631 Paper 30097071 Paper 30080841 Paper 29900673 Paper 29880586 Paper 29851933 Paper 29747685 Paper 29727246 Paper 29708546 Paper 29687032 Paper 29679656

View original record on NIH RePORTER →